Scientists hunt for clues in blood and skin to speed up CMT treatments
NCT ID NCT03386266
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study involved 156 people with Charcot-Marie-Tooth disease type 1A (CMT1A), a rare nerve condition that slowly gets worse. Researchers took blood and skin samples over two years to find biological markers that could show how the disease progresses. The goal was to develop more sensitive tools to measure whether future treatments actually work.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHARCOT-MARIE-TOOTH DISEASE, TYPE IA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Medical Center Goettingen
Goettigen, Lower Saxony, 37075, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.